doxycycline hyclate 50 MG Oral Tablet
- RxCUI
- 1652674
- RxNorm name
- doxycycline hyclate 50 MG Oral Tablet
- Display name
- Doxycycline (Oral Pill)
- Full name
- doxycycline hyclate 50 MG Oral Tablet
- Term type
- SCD
- Status
- Active
- Strength
- 50 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-11-12 18:37:13
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 072015
- Active start
- 072015
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| doxycycline hyclate | 50 MG / 1 EACH | doxycycline | doxycycline |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| doxycycline | 3640 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | doxycycline hyclate 50 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | doxycycline hyclate 50 MG Oral Tablet | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 6 | CODES | |
| RxCUI | 1652674 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 46708-499-60 | 46708-499 | Doxycycline Hyclate Doxycycline Hyclate | Alembic Pharmaceuticals Limited | ANDA210536 |
| 62135-625-60 | 62135-625 | Doxycycline Hyclate Doxycycline Hyclate | Chartwell RX LLC | ANDA062505 |
| 62332-499-60 | 62332-499 | Doxycycline Hyclate Doxycycline Hyclate | Alembic Pharmaceuticals Inc. | ANDA210536 |
| 64380-225-01 | 64380-225 | DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE | Strides Pharma Science Limited | ANDA062538 |
| 68999-625-60 | 68999-625 | Doxycycline Hyclate Doxycycline Hyclate | Chartwell Governmental & Specialty RX, LLC | ANDA062505 |
| 72143-262-60 | 72143-262 | Doxycycline Hyclate Doxycycline Hyclate | JG Pharma Inc. | ANDA062269 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA210536 | 46708-499 | Doxycycline Hyclate Doxycycline Hyclate | ANDA | Alembic Pharmaceuticals Limited |
| ANDA062505 | 62135-625 | Doxycycline Hyclate Doxycycline Hyclate | ANDA | Chartwell RX LLC |
| ANDA062538 | 64380-225 | DOXYCYCLINE HYCLATE DOXYCYCLINE HYCLATE | ANDA | Strides Pharma Science Limited |
| ANDA062269 | 72143-262 | Doxycycline Hyclate Doxycycline Hyclate | ANDA | JG Pharma Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxycycline | DOXYCYCLINE | Sun Pharmaceutical Industries Inc. | 8224b9c5-5c4b-4dda-bc58-47b6604c2884 | 2026-10-29 | Warnings, Adverse reactions | 63304013010 |
| doxycycline | DOXYCYCLINE | Chartwell RX LLC | 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 | 2026-10-16 | Warnings, Adverse reactions | 62135-625-60 62135-625 62135062560 1652674 |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Inc. | cff08863-7156-49d0-abbd-8f9274302886 | 2026-08-22 | Warnings, Adverse reactions | 62332-499-60 62332-499 62332049960 1652674 |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Strides Pharma Science Limited | 2deeee4f-b342-a178-e063-6394a90af897 | 2026-06-26 | Warnings, Adverse reactions | 64380-225-01 64380-225 64380022501 1652674 |
| TARGADOX | DOXYCYCLINE HYCLATE | Journey Medical Corporation | 83243f78-b984-46a4-a88a-c6a15c217b90 | 2025-10-21 | Warnings, Adverse reactions | 1652674 |
| doxycycline | DOXYCYCLINE | Chartwell Governmental & Specialty RX, LLC | b8486639-7eb9-4610-9cd4-0e922045d592 | 2025-09-30 | Warnings, Adverse reactions | 68999-625-60 68999-625 68999062560 1652674 |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | JG Pharma Inc. | 10b8bf71-4311-41e8-a891-bab8bc86863f | 2025-08-01 | Warnings, Adverse reactions | 72143-262-60 72143-262 72143026260 1652674 |
| Doxycycline | DOXYCYCLINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2bcde264-5f6f-47f6-ae2e-1b7010deacf7 | 2025-07-18 | Warnings, Adverse reactions | 23155013311 23155013301 23155013330 23155013305 |
| Doxycycline | DOXYCYCLINE | Lannett Company, Inc. | 4999bbd9-44ed-4749-9730-be2337bdf490 | 2024-07-03 | Warnings, Adverse reactions | 00527133501 |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 24c8472a-dd07-4f84-8bea-20a3f178d119 | 2023-01-27 | Warnings, Adverse reactions | 46708-499-60 46708-499 46708049960 1652674 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8a9e1d08-1665-46d2-bda6-aa11a3f18646 | doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD] | 2 | 21 | Doxycycline Hyclate Tablets, USP | 20231121 |
| 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 | doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD] | 2 | 16 | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | 20250930 |
| cff08863-7156-49d0-abbd-8f9274302886 | doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD] | 2 | 12 | Doxycycline Hyclate Tablets, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets, USP and other antibacterial drugs, doxycycline hyclate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20250830 |
| b8486639-7eb9-4610-9cd4-0e922045d592 | doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD] | 2 | 10 | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | 20250930 |
| 83243f78-b984-46a4-a88a-c6a15c217b90 | doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD] | 2 | 7 | TARGADOX ® (doxycycline hyclate USP) 50 mg tablets | 20251021 |
| 24c8472a-dd07-4f84-8bea-20a3f178d119 | doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD] | 2 | 3 | Doxycycline Hyclate Tablets, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets, USP and other antibacterial drugs, doxycycline hyclate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20230127 |
| 2deeee4f-b342-a178-e063-6394a90af897 | doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD] | 2 | 2 | Doxycycline Hyclate Tablets, USP | 20251120 |
| 10b8bf71-4311-41e8-a891-bab8bc86863f | doxycycline hyclate 50 MG Oral Tablet [PSN] · doxycycline hyclate 50 MG Oral Tablet [SCD] | 2 | 1 | Doxycycline Hyclate Tablets, USP 50 mg | 20250801 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 8224b9c5-5c4b-4dda-bc58-47b6604c2884 | DOXYCYCLINE TABLETS Rx only | Sun Pharmaceutical Industries Inc. | Ohm Laboratories Inc. | Hovione PharmaScience Limited | 20261029 |
| 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | Chartwell RX LLC | 20261016 |
| 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | Chartwell RX LLC | 20260929 |
| cff08863-7156-49d0-abbd-8f9274302886 | Doxycycline Hyclate Tablets, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets, USP and other antibacterial drugs, doxycycline hyclate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 20260822 |
| 2deeee4f-b342-a178-e063-6394a90af897 | Doxycycline Hyclate Tablets, USP | Strides Pharma Science Limited | Strides Pharma International AG | 20260626 |
| 37a8cb92-0ade-4fbc-80f7-2ef283bc32cb | Doxycycline Hyclate Tablets, USP 50 mg | JG Pharma Inc. | Caribe Holdings (Cayman) Co. Ltd. dba PuraCap Caribe | 20251212 |
| 2deeee4f-b342-a178-e063-6394a90af897 | Doxycycline Hyclate Tablets, USP | Strides Pharma Science Limited | Strides Pharma Global Pte. Ltd. | 20251120 |
| 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | Chartwell RX LLC | 20250930 |
| b8486639-7eb9-4610-9cd4-0e922045d592 | Doxycycline Hyclate Capsules, USP Doxycycline for Oral Suspension, USP Doxycycline Hyclate Tablets, USP | Chartwell Governmental & Specialty RX, LLC | 20250930 |
| cff08863-7156-49d0-abbd-8f9274302886 | Doxycycline Hyclate Tablets, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets, USP and other antibacterial drugs, doxycycline hyclate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 20250830 |
| 10b8bf71-4311-41e8-a891-bab8bc86863f | Doxycycline Hyclate Tablets, USP 50 mg | JG Pharma Inc. | 20250801 |
| 2bcde264-5f6f-47f6-ae2e-1b7010deacf7 | DOXYCYCLINE TABLETS, USP Rx only | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | USV Private Limited | 20250718 |
| 4999bbd9-44ed-4749-9730-be2337bdf490 | Doxycycline Tablets, USP | Lannett Company, Inc. | 20240703 |
| 8a9e1d08-1665-46d2-bda6-aa11a3f18646 | Doxycycline Hyclate Tablets, USP | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS | Caribe Holdings (Cayman) Co. Ltd. dba PuraCap Caribe | 20231121 |
| 24c8472a-dd07-4f84-8bea-20a3f178d119 | Doxycycline Hyclate Tablets, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets, USP and other antibacterial drugs, doxycycline hyclate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | Alembic Pharmaceuticals Limited | 20230127 |
| e57b06c0-d0cd-41ff-9ca5-279b11c15e1c | Doxycycline Hyclate Capsules, USP 50 mg and 100 mg Doxycycline Hyclate Tablets, USP 100 mg | A-S Medication Solutions | 20210415 |
| caa9928e-8cee-408c-ac72-bd6ce1390a70 | DOXYCYCLINE TABLETS, USP Rx only | Lake Erie Medical DBA Quality Care Products LLC | 20190425 |
| 8224b9c5-5c4b-4dda-bc58-47b6604c2884 | DOXYCYCLINE TABLETS Rx only | Sun Pharmaceutical Industries Inc. | Ohm Laboratories Inc. | Hovione PharmaScience Limited | 20180806 |
| 86e1102c-47bc-4f27-a4d0-7261b3deba63 | Doxycycline Tablets, USP | Par Pharmaceutical, Inc. | Par Pharmaceutical Inc. | 20170809 |
| 4ceb42f2-6585-4224-af3e-7d47ddfac5bb | National Council for Prescription Drug Programs | 20130213 | |
| eedd02ec-26d6-4dac-9ec9-8d86534bb961 | National Council for Prescription Drug Programs | 20120724 | |
| 7c386618-89c6-4393-bf1b-80debf22f1a6 | National Council for Prescription Drug Programs | 20120724 | |
| f6d50e6b-084b-4298-8f3d-3ea28f03b8c2 | National Council for Prescription Drug Programs | 20120724 | |
| b34bad0e-583b-416b-adf4-e847edfc22ce | National Council for Prescription Drug Programs | 20120724 | |
| 730d54e2-5cf3-4050-a6bb-a6d0302ceca8 | National Council for Prescription Drug Programs | 20120724 | |
| 1334e77b-86ce-4784-b613-f1544146c247 | National Council for Prescription Drug Programs | 20120724 | |
| bf667704-f439-4e8a-a4a5-dd150462a125 | Doak Dermatologics | 20070209 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A01AB | Antiinfectives and antiseptics for local oral treatment | ATC1-4 | doxycycline | |
| ATC | J01AA | Tetracyclines | ATC1-4 | doxycycline | |
| FDASPL | D013754 | Tetracyclines | CHEM | has_chemical_structure | doxycycline |
| FDASPL | N0000175882 | Tetracycline-class Drug | EPC | has_epc | doxycycline |
| MEDRT | D004318 | Doxycycline | CHEM | has_ingredient | doxycycline hyclate |
| MEDRT | D004318 | Doxycycline | CHEM | has_ingredient | doxycycline |
| MEDRT | D013752 | Tetracycline | CHEM | ci_chemclass | doxycycline |
| MEDRT | D013752 | Tetracycline | CHEM | ci_chemclass | doxycycline hyclate |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | doxycycline |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | doxycycline |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | doxycycline |
| MEDRT | D002771 | Cholera | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D002771 | Cholera | DISEASE | may_treat | doxycycline |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | doxycycline |
| MEDRT | D006100 | Granuloma Inguinale | DISEASE | may_treat | doxycycline |
| MEDRT | D006100 | Granuloma Inguinale | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | doxycycline |
| MEDRT | D008288 | Malaria | DISEASE | may_prevent | doxycycline |
| MEDRT | D008288 | Malaria | DISEASE | may_prevent | doxycycline hyclate |
| MEDRT | D009175 | Mycoplasma Infections | DISEASE | may_treat | doxycycline |
| MEDRT | D009175 | Mycoplasma Infections | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D010930 | Plague | DISEASE | may_treat | doxycycline |
| MEDRT | D010930 | Plague | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D010996 | Pleural Effusion | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D010996 | Pleural Effusion | DISEASE | may_treat | doxycycline |
| MEDRT | D018410 | Pneumonia, Bacterial | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D018410 | Pneumonia, Bacterial | DISEASE | may_treat | doxycycline |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | doxycycline hyclate |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | doxycycline |
| MEDRT | D009956 | Psittacosis | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D009956 | Psittacosis | DISEASE | may_treat | doxycycline |
| MEDRT | D012061 | Relapsing Fever | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D012061 | Relapsing Fever | DISEASE | may_treat | doxycycline |
| MEDRT | D012373 | Rocky Mountain Spotted Fever | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D012373 | Rocky Mountain Spotted Fever | DISEASE | may_treat | doxycycline |
| MEDRT | D012598 | Sclerosis | DISEASE | induces | doxycycline |
| MEDRT | D012598 | Sclerosis | DISEASE | induces | doxycycline hyclate |
| MEDRT | D013587 | Syphilis | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | D013587 | Syphilis | DISEASE | may_treat | doxycycline |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | doxycycline |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | doxycycline hyclate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | doxycycline hyclate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | doxycycline |
| MEDRT | N0000008334 | Cell Membrane Alteration | PE | has_pe | doxycycline hyclate |
| MEDRT | N0000008334 | Cell Membrane Alteration | PE | has_pe | doxycycline |
| MEDRT | N0000008732 | Decreased Mitosis | PE | has_pe | doxycycline hyclate |
| MEDRT | N0000008732 | Decreased Mitosis | PE | has_pe | doxycycline |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | doxycycline hyclate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | doxycycline |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 50 MG (expressed as doxycycline hyclate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | ANDA | ANDA062269 |
| CODES | ANDA | ANDA062505 |
| CODES | ANDA | ANDA062538 |
| CODES | ANDA | ANDA210536 |
| CODES | VUID | 4001963 |
| NAMES | Prescribable Synonym | doxycycline hyclate 50 MG Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |